Veterinary Oncology Market Size, Share, Growth, Trends, and Global Industry Analysis: By Treatment Type (Radiotherapy, Surgery, Chemotherapy, and Other Treatment Types), By Animal Type (Canine, Feline, and Other Animal Types), By Application (Lymphoma Cancer, Mast Cell Cancer, Mammary and Squamous Cell Cancer, and Other Applications) and Region Forecast 2024-2030

Veterinary Oncology Market size was valued at US$ 1,382.1 million in 2023 and growing at a CAGR of 11.3% from 2024-2030. Veterinary oncology is the specialty concerned with improving the prognosis of cancer-stricken dogs. One of the main causes of death for companion animal is cancer. Skin and bone cancers are more common in dogs and cats. Because domestic animals' skin is constantly exposed to the sun's rays, skin tumors are the most prevalent and often diagnosed cancer in them.

The rise in demand for veterinary oncology therapy, the prevalence of cancer, including skin, mast cell, and bone cancer, as well as an increase in funding for animal care centers from both public and private sources, as well as an increase in research and development for oncology treatment in pets, are the main factors driving the growth of the global veterinary oncology market. In 2020, it was revealed by the Flint Animal Cancer Center that over 85% of bone tumor diagnoses occur in dogs.

For instance, The American Veterinary Medical Association reported in January 2021 that the number of new pets per clinic increased from 25% weekly in March 2020 to 39% weekly in July 2020. Furthermore, because dogs and cats are more likely to develop cancer, there is an increased focus on pet health, which contributes to the market's growth. It was revealed in the Journal of the American Animal Hospital Association that dogs have a higher risk of developing cancer.

However, the market expansion is anticipated to be restricted by the high cost of veterinary oncology therapy and the side effects of oncology medications, which include hair loss, decreased appetite, and vomiting. Furthermore, growth in the number of veterinary clinical centers to provide cutting-edge therapy and an increase in public knowledge of the management and treatment of oncology in pet treatments are anticipated to offer lucrative opportunities for the growth of the worldwide veterinary oncology market.

Key Developments

• In September 2023, A study by FidoCure, which was published, highlighted different precision medicine methods that veterinarians could use to better understand hemangiosarcoma (HSA), a frequent and severe canine cancer. For dog owners, receiving an HSA diagnosis can be distressing because it requires a painful and drawn-out diagnosing process. Therefore, hemangiosarcoma genome sequencing can yield information that will enable vets to better understand the prognosis of HSA patients and empower pet parents to make decisions about their pets' lives and deaths.
• In July 2023, by utilizing FidoCure's genetic testing and precision medicine platform, Ardent Animal Health and the company teamed to increase access to oncology breakthroughs in veterinary medicine